spacer
home > epc > autumn 2018 > clinical service
PUBLICATIONS
European Pharmaceutical Contractor

Clinical Service

With the NHS currently facing some of its greatest challenges in a 70-year history, clinical trials for new treatments and technologies could provide the solutions to seemingly insurmountable problems: endless surgery waiting lists, bed-blocking, and clinicians and nurses stretched to their limit. Do public-private partnerships between the NHS and medical technology developers hold the key?

Successful outcomes in device development and the development of clinical and health economic benefits rely heavily on the strong partnerships between clinicians and med-tech developers, with both parties committed to improving outcomes for patients. The clinicians that embrace innovation and that are forward-thinking must be championed. Collaborating with those willing to invest in and introduce evidence-based therapies to simplify treatments will help build a more robust health system that is moving forward, rather than stuck in its tracks under strain.

2018 marks the NHS’s 70th birthday, and, as the British institution celebrates 70 years of service, the general public rushed to express their gratitude; from cradle to grave, the NHS is hailed for its care for every citizen, no matter their condition, circumstance, or means.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bernard Ross is the CEO at Sky Medical Technology, a UK-based medical devices company. Bernard and the company develop a range of products tailored to the needs of different medical application areas, selling both directly and through strategic partnerships or distributors in each major clinical area. Clinical areas of interest include reduction of oedema, prevention of venous thromboembolism, wound healing, and elite sport recovery.
spacer
Bernard Ross
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.
More info >>

White Papers

Modular Feeding Systems for Prefilled Syringes and Injection Devices

Dividella

The pre-filled syringe and injection device is an increasingly attractive presentation for both new and established parenteral pharmaceuticals. We will explore how innovative carton packaging solutions can enhance this presentation whilst meeting the stringent requirements of product protection.
More info >>

 
Industry Events

Respiratory Drug Delivery (RDDŽ) Europe 2019

7-10 May 2019, Estoril Congress Center, Lisbon

Respiratory Drug Delivery (RDDŽ) Europe 2019 connects emerging and high-level scientists, academics, industrial and regulatory specialists, and clinicians. It is a must-attend conference for companies involved in research, development, testing or marketing of medicines, devices and services associated with pulmonary or nasal pharmaceutical products. This year, RDD Europe 2019 will be held in Estoril (Lisbon), Portugal, May 7-10, 2019, and, as in previous years is jointly organized by RDD Online and Aptar Pharma.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement